Biopharma Co. Maxygen Fears Amgen Might Sue

By Amanda Ernst · June 13, 2008, 12:00 AM EDT

Biopharmaceutical company Maxygen Inc. has warned that Amgen Inc. might look to file a patent infringement suit against the company when it starts seeking regulatory approval for MAXY-G34, its treatment for...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Amanda

August 13, 2008
FTC OKs Sun's Taro Buy After Divestitures
August 08, 2008
Some Counterclaims Dropped From Coreg Patent Suit
July 28, 2008
Seven Patents Dropped From GE Patent Battle
July 28, 2008
Stent Inventor Sues Abbott For Infringement
July 22, 2008
FTC, Virginia Hospitals' Attorney Debate Broken Deal
July 09, 2008
Apotex Acular ANDA Infringes Roche: Fed. Circ.
July 09, 2008
MediCor Receives Fourth Exclusivity Extension
July 02, 2008
Pfizer Wins Dismissal Of 4 Claims From Celebrex Suit
June 27, 2008
Boehringer's Mirapex Patent Declared Invalid
June 13, 2008
Stryker Faces Yet Another Suit Over Pain Pump